Curis Lifescien.
Fundamental Score
Curis Lifescien. Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of CURIS across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Return on Equity (55.32%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (34.24%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Attractive Valuation (P/E: 16.80 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Strong Interest Coverage (8.45x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (68.03%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
2 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Curis Lifescien.
About CURIS
Company Details
CURIS Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Curis Lifescien. (CURIS)?
As of 01 Dec 2025, 04:21 pm IST, Curis Lifescien. (CURIS) is currently trading at ₹127.00. The stock has a market capitalization of ₹102.67 (Cr).
Is CURIS share price Overvalued or Undervalued?
CURIS is currently trading at a P/E ratio of 16.80x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Curis Lifescien. share price?
Key factors influencing CURIS's price include its quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Curis Lifescien. a good stock for long-term investment?
Curis Lifescien. shows a 5-year Profit Growth of N/A% and an ROE of 55.32%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.96 before investing.
How does Curis Lifescien. compare with its industry peers?
Curis Lifescien. competes with major peers in the Pharmaceuticals. Investors should compare CURIS's P/E of 16.80x and ROE of 55.32% against the industry averages to determine its competitive standing.
What is the P/E ratio of CURIS and what does it mean?
CURIS has a P/E ratio of 16.80x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹17 for every ₹1 of annual earnings.
How is CURIS performing according to Bull Run's analysis?
CURIS has a Bull Run fundamental score of 7.3/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does CURIS belong to?
CURIS operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Curis Lifescien..
What is Return on Equity (ROE) and why is it important for CURIS?
CURIS has an ROE of 55.32%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Curis Lifescien. generates profits from shareholders' equity.
How is CURIS's debt-to-equity ratio and what does it indicate?
CURIS has a debt-to-equity ratio of 0.96, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is CURIS's dividend yield and is it a good dividend stock?
CURIS offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has CURIS grown over the past 5 years?
CURIS has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in CURIS and why does it matter?
Promoters hold 68.03% of CURIS shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is CURIS's market capitalization category?
CURIS has a market capitalization of ₹103 crores, placing it in the Small-cap category.
How volatile is CURIS stock?
CURIS has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for CURIS?
CURIS has a 52-week high of ₹N/A and low of ₹N/A.
What is CURIS's operating profit margin trend?
CURIS has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is CURIS's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of N/A% and YoY Profit Growth of N/A%.
What is the institutional holding pattern in CURIS?
CURIS has FII holding of 2.93% and DII holding of 10.86%. Significant institutional holding often suggests professional confidence in the stock.